Preferred Label : thrombin time;
MeSH definition : Clotting time of PLASMA mixed with a THROMBIN solution. It is a measure of the conversion
of FIBRINOGEN to FIBRIN, which is prolonged by AFIBRINOGENEMIA, abnormal fibrinogen,
or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products,
or HEPARIN. BATROXOBIN, a thrombin-like enzyme unaffected by the presence of heparin,
may be used in place of thrombin.;
MeSH synonym : time, reptilase; times, thrombin; thrombin times; time, thrombin; reptilase time; reptilase times; times, reptilase;
MeSH annotation : usually NIM;
Origin ID : D013918;
UMLS CUI : C0677634;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Record concept(s)
See also
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Clotting time of PLASMA mixed with a THROMBIN solution. It is a measure of the conversion
of FIBRINOGEN to FIBRIN, which is prolonged by AFIBRINOGENEMIA, abnormal fibrinogen,
or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products,
or HEPARIN. BATROXOBIN, a thrombin-like enzyme unaffected by the presence of heparin,
may be used in place of thrombin.
http://thesesante.ups-tlse.fr/2096/
2017
false
false
false
France
French
dissertations, academic
thrombin time
nomenclature
generations
thrombin time
terminology
family characteristics
---
http://www.has-sante.fr/portail/jcms/c_1009982/biologie-des-anomalies-de-lhemostase-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084558/biologie-anomalie-hemostase-t1-temps-de-saignement-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084559/biologie-anomalie-hemostase-t2-thrombine-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084560/biologie-anomalie-hemostase-t3-tap-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084561/biologie-anomalie-hemostase-t4-ac-anti-f4p-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084562/biologie-anomalie-hemostase-t5-inhibiteurs-fah-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084563/biologie-anomalie-hemostase-t6-al-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084564/biologie-anomalie-hemostase-t7-mutations-fii-et-fv-rapport-d-evaluation
2011
true
France
French
health technology assessment
hemostatic disorders
bleeding time
thrombin time
platelet aggregation
platelet factor 4
factor VIII
lupus coagulation inhibitor
factor v
prothrombin
factor V leiden
---